Paul F Jacobson - Net Worth and Insider Trading
Paul F Jacobson Net Worth
The estimated net worth of Paul F Jacobson is at least $514,960 dollars as of 2025-07-22. Paul F Jacobson is the Director of Progenics Pharmaceuticals Inc and owns about 125,600 shares of Progenics Pharmaceuticals Inc (PGNX) stock worth over $514,960. Details can be seen in Paul F Jacobson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul F Jacobson has not made any transactions after 2008-10-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Paul F Jacobson
Paul F Jacobson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul F Jacobson owns 1 companies in total, including Thorne HealthTech Inc (THRN) .
Click here to see the complete history of Paul F Jacobson’s form 4 insider trades.
Insider Ownership Summary of Paul F Jacobson
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
THRN | Thorne HealthTech Inc | 2021-09-22 | director & 10 percent owner & Chief Executive Officer |
Paul F Jacobson Latest Holdings Summary
Paul F Jacobson currently owns a total of 1 stock. Paul F Jacobson owns 125,600 shares of Progenics Pharmaceuticals Inc (PGNX) as of October 23, 2008, with a value of $514,960.
Latest Holdings of Paul F Jacobson
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PGNX | Progenics Pharmaceuticals Inc | 2008-10-23 | 125,600 | 4.10 | 514,960 |
Holding Weightings of Paul F Jacobson
Paul F Jacobson Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul F Jacobson has made a total of 0 transactions in Progenics Pharmaceuticals Inc (PGNX) over the past 5 years. The most-recent trade in Progenics Pharmaceuticals Inc is the sale of 62,500 shares on October 23, 2008, which brought Paul F Jacobson around $577,500.
Insider Trading History of Paul F Jacobson
- 1
Paul F Jacobson Trading Performance
Paul F Jacobson Ownership Network
Ownership Network List of Paul F Jacobson
Ownership Network Relation of Paul F Jacobson

Paul F Jacobson Owned Company Details
What does Thorne HealthTech Inc do?
Who are the key executives at Thorne HealthTech Inc?
Paul F Jacobson is the director & 10 percent owner & Chief Executive Officer of Thorne HealthTech Inc. Other key executives at Thorne HealthTech Inc include 10 percent owner Kirin Holdings Company, Ltd /fi , Chief Financial Officer Bryan K. Conley , and Chief Financial Officer Scott Wheeler .
Thorne HealthTech Inc (THRN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Thorne HealthTech Inc (THRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Thorne HealthTech Inc (THRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Thorne HealthTech Inc (THRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Thorne HealthTech Inc Insider Transactions
Paul F Jacobson Mailing Address
Above is the net worth, insider trading, and ownership report for Paul F Jacobson. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Paul F Jacobson's mailing address is: Bedford Ny 10506.